These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 8459084)

  • 21. Emulsified isoflurane produces cardiac protection after ischemia-reperfusion injury in rabbits.
    Rao Y; Wang YL; Zhang WS; Liu J
    Anesth Analg; 2008 May; 106(5):1353-9, table of contents. PubMed ID: 18420844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cholinergic and alpha-adrenergic coronary vasomotion [corrected] with increasing ischemia-reperfusion injury.
    Ehring T; Krajcar M; Baumgart D; Kompa S; Hümmelgen M; Heusch G
    Am J Physiol; 1995 Feb; 268(2 Pt 2):H886-94. PubMed ID: 7864216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bimakalim, an ATP-sensitive potassium channel opener, mimics the effects of ischemic preconditioning to reduce infarct size, adenosine release, and neutrophil function in dogs.
    Mizumura T; Nithipatikom K; Gross GJ
    Circulation; 1995 Sep; 92(5):1236-45. PubMed ID: 7648671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective inhibition of the contractile apparatus. A new approach to modification of infarct size, infarct composition, and infarct geometry during coronary artery occlusion and reperfusion.
    Garcia-Dorado D; Théroux P; Duran JM; Solares J; Alonso J; Sanz E; Munoz R; Elizaga J; Botas J; Fernandez-Avilés F
    Circulation; 1992 Mar; 85(3):1160-74. PubMed ID: 1537114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Salvage of ischaemic myocardium by reperfusion: importance of collateral blood flow and myocardial oxygen demand during occlusion.
    Przyklenk K; Vivaldi MT; Schoen FJ; Malcolm J; Arnold O; Kloner RA
    Cardiovasc Res; 1986 Jun; 20(6):403-14. PubMed ID: 3779738
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of ethanol on myocardial infarct size in a canine model of coronary artery occlusion-reperfusion.
    Itoya M; Morrison JD; Downey HF
    Mol Cell Biochem; 1998 Sep; 186(1-2):35-41. PubMed ID: 9774183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coronary venous retroinfusion of felodipine reduces myocardial necrosis after coronary occlusion and reperfusion.
    Hatori N; Haga Y; Sjöquist PO; Nordlander M; Rydén L
    J Cardiovasc Pharmacol; 1993 Jul; 22(1):160-6. PubMed ID: 7690089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduction in reperfusion-induced myocardial necrosis in dogs by RheothRx injection (poloxamer 188 N.F.), a hemorheological agent that alters neutrophil function.
    Schaer GL; Hursey TL; Abrahams SL; Buddemeier K; Ennis B; Rodriguez ER; Hubbell JP; Moy J; Parrillo JE
    Circulation; 1994 Dec; 90(6):2964-75. PubMed ID: 7994844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Marked reduction in myocardial infarct size due to prolonged infusion of an antioxidant during reperfusion.
    Horwitz LD; Fennessey PV; Shikes RH; Kong Y
    Circulation; 1994 Apr; 89(4):1792-801. PubMed ID: 8149545
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperoxic reperfusion is required to reduce infarct size after intravenous therapy with perfluorochemical (Fluosol-DA 20%) or its detergent component (poloxamer 188) in a poorly collateralized animal model. Absence of a role of polymorphonuclear leukocytes.
    Kolodgie FD; Farb A; Carlson GC; Wilson PS; Virmani R
    J Am Coll Cardiol; 1994 Oct; 24(4):1098-108. PubMed ID: 7930204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endogenous prostaglandin endoperoxides may alter infarct size in the presence of thromboxane synthase inhibition: studies in a rabbit model of coronary artery occlusion-reperfusion.
    Golino P; Ambrosio G; Villari B; Ragni M; Focaccio A; Pace L; de Clerk F; Condorelli M; Chiariello M
    J Am Coll Cardiol; 1993 Feb; 21(2):493-501. PubMed ID: 8426016
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retrograde infusion of lidocaine or L-arginine before reperfusion reduces myocardial infarct size.
    Lee R; Nitta T; Schmid RA; Schuessler RB; Harris KM; Gay WA
    Ann Thorac Surg; 1998 May; 65(5):1353-9. PubMed ID: 9594866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Administration of bovine polymerized haemoglobin before and during coronary occlusion reduces infarct size in rabbits.
    Rempf C; Standl T; Schenke K; Chammas K; Gottschalk A; Burmeister MA; Gottschalk A
    Br J Anaesth; 2009 Oct; 103(4):496-504. PubMed ID: 19710071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparison of effects of verapamil and those of nicardipine on myocardial ischemia and reperfusion injury: a study in an in situ rabbit model].
    Furuya M; Yoshida K
    Masui; 1999 Oct; 48(10):1074-82. PubMed ID: 10554498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Limitation of Infarct Size and No-Reflow by Intracoronary Adenosine Depends Critically on Dose and Duration.
    Yetgin T; Uitterdijk A; Te Lintel Hekkert M; Merkus D; Krabbendam-Peters I; van Beusekom HMM; Falotico R; Serruys PW; Manintveld OC; van Geuns RM; Zijlstra F; Duncker DJ
    JACC Cardiovasc Interv; 2015 Dec; 8(15):1990-1999. PubMed ID: 26738671
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardioprotection by ischemic and nonischemic myocardial stress and ischemia in remote organs. Implications for the concept of ischemic preconditioning.
    Verdouw PD; Gho BC; Koning MM; Schoemaker RG; Duncker DJ
    Ann N Y Acad Sci; 1996 Sep; 793():27-42. PubMed ID: 8906153
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Timely administration of AICA riboside reduces reperfusion injury in rabbits.
    Kingma JG; Simard D; Rouleau JR
    Cardiovasc Res; 1994 Jul; 28(7):1003-7. PubMed ID: 7954584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dynamic progression of contractile and endothelial dysfunction and infarct extension in the late phase of reperfusion.
    Zhao ZQ; Nakamura M; Wang NP; Velez DA; Hewan-Lowe KO; Guyton RA; Vinten-Johansen J
    J Surg Res; 2000 Dec; 94(2):133-44. PubMed ID: 11104653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The "wavefront phenomenon" of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow.
    Reimer KA; Jennings RB
    Lab Invest; 1979 Jun; 40(6):633-44. PubMed ID: 449273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fatty acid analogue accumulation: a marker of myocyte viability in ischemic-reperfused myocardium.
    Miller DD; Gill JB; Livni E; Elmaleh DR; Aretz T; Boucher CA; Strauss HW
    Circ Res; 1988 Oct; 63(4):681-92. PubMed ID: 3048774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.